Kezar Life Sciences Inc (KZR)
0.8574
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.8548
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Cash from Financing (Quarterly): 0.059M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.059M |
| September 30, 2023 | 0.043M |
| June 30, 2023 | 0.382M |
| March 31, 2023 | 0.154M |
| December 31, 2022 | 0.506M |
| September 30, 2022 | 0.185M |
| June 30, 2022 | 78.32M |
| March 31, 2022 | 48.85M |
| December 31, 2021 | 99.36M |
| September 30, 2021 | 2.212M |
| June 30, 2021 | 0.282M |
| March 31, 2021 | 10.74M |
| December 31, 2020 | 0.317M |
| September 30, 2020 | 1.962M |
| Date | Value |
|---|---|
| June 30, 2020 | 44.00M |
| March 31, 2020 | 53.37M |
| December 31, 2019 | 0.08M |
| September 30, 2019 | 0.008M |
| June 30, 2019 | 0.18M |
| March 31, 2019 | 0.004M |
| December 31, 2018 | 0.005M |
| September 30, 2018 | -1.087M |
| June 30, 2018 | 78.97M |
| March 31, 2018 | 0.025M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 7.341M |
| June 30, 2017 | 42.41M |
| March 31, 2017 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
0.008M
Minimum
Sep 2019
99.36M
Maximum
Dec 2021
17.95M
Average
0.382M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| Accuray Inc | -0.257M |
| Tonix Pharmaceuticals Holding Corp | 40.71M |
| Acumen Pharmaceuticals Inc | 29.13M |
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.98M |
| Cash from Investing (Quarterly) | 27.88M |
| Free Cash Flow | -83.46M |
| Free Cash Flow Per Share (Quarterly) | -0.2609 |
| Free Cash Flow Yield | -134.2% |